Filing Flows

Filing Flows › Aterian (ATER) › Recalls, complaints & regulation

Aterian (ATER): recalls

Aterian (ATER) beyond its filings: 1 recall in the last 12 months (1 in five years, 0 Class I).

Latest recalls

Aterian's latest quarter

Aterian, Q2 2026: revenue $7K (-100% year over year), net loss $491K, operating cash flow $438K. The chart follows the revenue to costs, profit and cash.

Questions

Has Aterian had any recalls?

1 recall on file over five years from the FDA, CPSC and NHTSA; 1 in the last 12 months.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.